Fitoestrogeny – rola prozdrowotna i zawartość w produktach

1. Bartnikowska E. Żywienie a choroby cywilizacyjne. Roczniki Warszawskiej Szkoły Zdrowia, IV, 5-10. 2. Woy-Wojciechowska J. Recepta na długie i zdrowe życie. Roczniki Warszawskiej Szkoły Zdrowia, 2:5-16. 3. Tham DM, Gardner CD. Potential health benefits of dietary phytoestrogens: a review of clinical, epidemiological and mechanistic evidence. J Clin Endocrinol Metab 1998; 83:2223-5. 4. Brouns F. Soya isoflavones: a new and promising ingredient for the health foods sector. Food Research International 2002; 35:187-93. 5. Dixon R.A., Ferreira D. Genistein. Phytochem 2002; 60:205-11. 6. Tomaszewski J. Fitoestrogeny w: klimakterium, hormonalna terapia zastępcza, poradnik terapeutyczny, pod red. JA Jakowickiego, Bifolium, Lublin 2001. 7. Fletcher RJ. Food sources of phyto-estrogens and their precursors in Europe. Brit J Nutr 2003; 89:39-43. 8. Koss-Annese B. Alternative therapies for menopause. Clin Obstet Gynec 2000; 43:162-83. 9. Kurzer M, XU X. Dietary phytoestrogens. Annu Rev Nutr 1997; 17:353-81. 10. Murkies A, Wilcox G, Davis S. Phytoestrogens. J Clin Endocrinol Metab 1998; 83:297-303. 11. Raffaelli B, Hoikkala A, Leppala E i wsp. Enterolignans. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 777:29-43. 12. www.nal.usda.gov/fnic/foodcomp/Data/isoflav/isfl_tbl.pdf. 13. Thompson LU, Robb P, Serraino M i wsp. Mammalian lignan production from various foods. Nutrition and Cancer 1991; 16:43-52. 14. Kim J-S, Kwon Ch-S. Estimated dietary isoflavone intake of Korean population based on National Nutrition Survey. NutritRes 2001; 21:947-53. 15. Van Erp-Baart M-A, Brants A, Kiely M i wsp. Isoflavone intake in four different European countries: the VENUS approach. Brit J Nutr 2003; 89 Suppl:25-30. 16. Setchell K, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999; 129:758-67. 17. Miksicek R. Estrogenic flavonoids: structural requirements for biological activity. Proc Soc Exp Biol Med 1995; 208:44-50. 18. Bingham S, Atkinson C. Liggins J i wsp. Phyto-oestrogens: where are we now? Br J Nutr 1998; 79:393-406. 19. Whitten P, Patisaul H. Cross-species and interassay comparisons of phytoestrogen action. Environ Health Perspect 2001; 109:1-20. 20. Adlercreutz C, Yamada T, Wahala K i wsp. Material and neonatal phytoestrogens in Japanese women Turing birth. Am J Obstet Gynecol 1999; 180: 737-43. 21. Rowland I, Faughnan M, Hoey L i wsp. Bioavailability of phyto-oestrogens. Brit J Nutri 2003; 89 Supp:45-58. 22. Messina MJ, Loprinzi CL. Soy for breast cancer survivors a critical review of the literature. J Nutr 2001; 131:3095-108. 23. Yamamoto S, Sobue T, Kobayashi M i wsp. Soy, isoflavones and breast cancer risk in Japan. J Natl Cancer Inst 2003; 18,95: 906-913. 24. Prescha A, Biernat J. Wpływ fitoestrogenów pokarmowych na organizm człowieka, Bromat Chem Toksykol 2008; XLI; 4:941-8. 25. Mense SM, Hei TK, Ganju RK i wsp. Phytoestrogens and breast cancer prevention: possible mechanisms of action. Environ. Health Perspect 2008; 116:426-33. 26. Cassidy A. Potential Risk and Benefits of Phytoestrogen-Rich Diets. Int J Vitam Nutr Res 2003; 73(2):120-6. 27. Ziegler RG. Phytoestrogens and Breast Cancer. Am J Clin Nutr 2004; 79:183-4. 28. Grynkiewicz G, Achmatowicz O, Pucko W. Bioaktywny izoflawon genisteina - perspektywy zastosowań medycznych. Post Fitoter 2000; 3:15-20. 29. Mason P. Nutrition: Isoflavones. Pharm J 2001; 266:16-9. 30. Wu AH, Yu MC, Tseng CC i wsp. Epidemiology of soy exposures and breast cancer risk. B J Cancer 2008; 98:9-14. 31. Cotterchio M, Boucher BA, Kreiger N i wsp. Dietary phytoestrogen intake - lignans and isoflavones - and breast cancer risk (Canada), Cancer Causes Control 2008; 19:259-72. 32. Hedelin M, Augustsson Balter K, Chang E i wsp. Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer. Prostate 2006; 66(14):1512-20. 33. Nestel P. Isoflavones: effects on cardiovascular risk and functions. International Congress Series 2004; 1262: 317-9. 34. Benassayag C, Perrot-Applanat M, Ferre F. Phytoestrogens as modulators of steroid action in target cells. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 777:233-48. 35. Messina M. Soyfoods and soybean phyto-oestrogens (isoflavones) as possible alternatives to hormone replacement therapy (HRT). Europ J Cancer 2000; 36; Sup. 4:71-2. 36. Tham DM, Gardner CD, Haskell WL. Clinical Review 97: potencial benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998; 83:2223-35. 37. Adlercreutz H, Mazur W. Phytoestrogens and western disease. Annals of Medicine 1997; 29:95-120. 38. Anderson JB, Anthony M, Messina M i wsp. Effects of phyto-oestrogens on tissues. Nutrition Research Reviews 1999; 12:75-116. 39. Cassidy A, Griffin B. Phyto-oestrogens: a potential role in the prevention of CHD? Proceedings of the Nutrition Society 1999; 58:193-9. 40. Button B, Patel N. Phytoestrogens for osteoporosis. Crit Rev Bone Mineral Metab 2004; 2:341-56. 41. Duncan AM, Phipps WR, Kurzer M. Phyto-oestrogens. Best Pract Res Clin Endocrinol Metab 2003; 17:253-71. 42. Kleszcz H. Osteoporoza - wielki problem zdrowotny. Magazyn Medyczny 1994; 6:34-6. 43. Branca F. Dietary phyto-oestrogens and bone health. Proc Nutr Soc 2003; 62:877-87. 44. Lee K, Coi E. Biochanin A stimulates osteoblastic differentiation and inhibits hydrogen peroxide-induced production of inflammatory mediators in MC3T3-E1 cells. Biol Pharm Bull 2005; 28:1948-53. 45. Marini H, Minutoli L, Polito F i wsp. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women. Ann Intern Med 2007; 146:839-47. 46. Atkinson SA, Ward WE. Clinical nutrition: 2. The role of nutrition in the prevention and treatment of adult osteoporosis. Canadian Medical Association Journal 2001; 165(11):1511. 47. Potter SM, Baum JA, Teng G i wsp. Soya protein and isoflavones: their effect on blood lipids and bone density in postmenopausal woman. Am J Clin Nutr 1998; 68:1375-379.